slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
165,241-165,300 of 319,975
40
The slide includes a specific callout for organic revenue growth and a disclaimer regarding corporate cost allocation.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
The slide includes a specific callout for +28% organic revenue growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics like Constant Currency and Organic Change.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The table includes reported, constant currency, and organic change metrics.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
Includes detailed footnotes regarding non-GAAP adjustments and currency impacts.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
Includes footnotes regarding non-GAAP metrics and segment reporting.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
The slide highlights a 12% organic growth for the Salix segment.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide highlights a 10% organic revenue growth for the International Rx segment.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
The slide includes a specific callout for Global Solta's organic revenue growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
Includes non-GAAP metrics like EBITA and organic change.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
The table tracks revenue in millions for 10 products from 2Q20 to 2Q21.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
54
The table provides a comparative view of product revenue across five quarters (2Q20 to 2Q21).Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
The table tracks 10 products across 5 quarters, totaling 50 data points.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
56
The table tracks revenue in millions for 10 products across 5 quarters (2Q20 to 2Q21).Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
57
Data represents U.S. only sales.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
58
The table lists 10 products with their respective revenue figures for 2Q21, 1Q21, 4Q20, 3Q20, and 2Q20.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
59
The table reconciles net loss to adjusted net income (non-GAAP) by detailing specific adjustments like amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
60
Includes footnotes regarding non-GAAP adjustments and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
61
The table provides a breakdown of specific financial line items for Bausch + Lomb, likely for reconciliation or segment reporting purposes.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
62
The slide includes two distinct tables: one for revenue and one for segment profit/EBITA.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
63
Includes footnotes regarding the definition of Bausch Pharma, estimate status, and inclusion of specific costs in G&A.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
Contains footnotes regarding non-GAAP adjustments and reporting basis.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
65
The table provides a detailed breakdown of financial metrics for the International Rx segment, including non-GAAP profit measures.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The table breaks down financial metrics for Ortho Dermatologics and Global Solta, providing a detailed view of segment profitability.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
67
Contains footnotes regarding non-GAAP information and segment reporting structure.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
68
The slide presents two separate tables for Q2 2021 and Q2 2020, detailing adjustments for items like amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
69
The slide contains two distinct tables for 2021 and 2020, detailing various expense adjustments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
70
Contains multiple tables for quarterly and annual financial data.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
71
The table reconciles GAAP to non-GAAP figures by adding back acquisition-related costs and adjustments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
72
The table provides a detailed breakdown of various financial adjustments including impairments, restructuring costs, and other non-recurring items.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
73
Contains two separate tables: one for annual periods (2017-2020) and one for quarterly periods (2020-2021).Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
74
Standard financial reconciliation table format.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
75
The table provides a detailed breakdown of revenue adjustments including exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
76
The table adjusts reported revenue for changes in exchange rates and divestitures/discontinuations to arrive at organic revenue.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
77
The slide presents two side-by-side tables representing different periods for comparison.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
78
The table is split into two main sections comparing current periods to prior periods to derive organic growth.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
79
The table reconciles reported revenue to organic revenue by adjusting for exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
80
The slide provides a detailed breakdown of adjustments (exchange rates, divestitures) to arrive at non-GAAP organic revenue figures.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
81
The table reconciles GAAP operating cash flow to a non-GAAP adjusted figure by adding back legacy legal settlements, separation costs, and adjusting for Amoun operating activities.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
82
The table reconciles Net loss to Adjusted EBITDA by adding back interest, taxes, depreciation, and various non-recurring or non-cash adjustments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
83
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
84
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
85
The right-hand sidebar lists the specific non-GAAP measures being defined in the appendix.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
86
The right-hand sidebar lists specific non-GAAP measures being disclosed in the appendix.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
87
The slide serves as a glossary/disclosure page for financial metrics.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
88
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
89
This slide serves as a glossary/methodology reference for financial reporting.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
90
The slide features a sidebar navigation menu listing various non-GAAP metrics.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
01
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations 1 hit
02
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations 1 hit
03
This is a standard pharmaceutical regulatory disclosure slide.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations 1 hit
04
Includes specific adverse reaction percentages for different age groups and reporting instructions.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations 1 hit
05
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations 1 hit
06
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · Problem1 hit
07
The slide uses a process-flow style diagram to connect internal capabilities to pipeline output and future market launches.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
08
The slide uses a structured layout to categorize achievements into three main pillars: COVID-19 vaccine, pipeline expansion, and corporate updates.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
09
Slide 9 of a BioNTech presentation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit